Devsta Pharmatech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-01-2025
- Paid Up Capital ₹ 0.10 M
as on 04-01-2025
- Company Age 3 Year, 5 Months
About Devsta Pharmatech
The Company is engaged in the Electrnoics Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Kushwaha, Chirau Dave, and Vimalkumar Panchal serve as directors at the Company.
- CIN/LLPIN
U29308GJ2021PTC124960
- Company No.
124960
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 2021
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Devsta Pharmatech Private Limited offer?
Devsta Pharmatech Private Limited offers a wide range of products and services, including Dryers & Evaporators, Medical Air Dryer, Material Handling Machines & Systems, Loading Machinery, Milling & Grinding Tools, Grinding Machines, Industrial Mixers & Homogenizers, Industrial Mixers, Pharmaceutical Machinery & Equipment, Pharmaceutical Machines.
Who are the key members and board of directors at Devsta Pharmatech?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chirau Dave  | Managing Director | 18-Aug-2021 | Current |
| Sanjay Kushwaha | Managing Director | 18-Aug-2021 | Current |
| Vimalkumar Panchal | Managing Director | 18-Aug-2021 | Current |
Board Members(0)
| Name | Designation | Appointment Date | Status |
|---|
Financial Performance of Devsta Pharmatech.
Enhance accessibility to Devsta Pharmatech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Devsta Pharmatech?
Unlock access to Devsta Pharmatech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Devsta Pharmatech?
Devsta Pharmatech has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Devsta Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Devsta Pharmatech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
